Treatment remained well-tolerated with consistent injection feasibility in 103 heavily pre-treated patients with R/M-HNSCC naïve or resistant to anti-PD-163% (26/41)…
September 26, 2025 16:05 ET | Source: Silynxcom Ltd. Netanya, Israel, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Silynxcom Ltd. (NYSE…
September 26, 2025 16:04 ET | Source: Maris-Tech Ltd. The company continues to advance AI-powered video streaming and edge computing…
TORONTO and HOUSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage…
September 25, 2025 16:30 ET | Source: Teva Pharmaceutical Industries Ltd TEL AVIV, Israel, Sept. 25, 2025 (GLOBE NEWSWIRE) --…
CHICAGO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a…
WhatLatest Euro NCAP AD results published online and via social media.WhenWednesday 24 September - 11:00 a.m. CEST.WhereGo to Euro NCAP's Press Releases or access videos…
Ad hoc announcement pursuant to Art. 53 LR A conference call will be held on September 23, 2025, at 14:00…
September 19, 2025 16:18 ET | Source: MBX Biosciences, Inc. CARMEL, Ind., Sept. 19, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences,…
SKY-0515 achieves dose-dependent reductions of mutant huntingtin (mHTT) protein, with 62% lowering at Day 84 on the 9mg daily oral…